The Report Guru

According to the new market research report the remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492 The prominent players operating in the remote patient monitoring market include BioTelemetry Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG Germany, OMRON Healthcare (Japan), ALTEN Calsoft Labs (France), Preventice Solutio

According to the new market research report Diagnostic Electrocardiograph Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 The growth in the diagnostic electrocardiograph market can primarily be attributed to factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices. The major players in the global diagnostic electrocardiograph market are Koninklijke Philips (Netherlands), GE Healthcare (US), and Nihon Kohden Corporation (Japan). These players have adopted various growth strategies such as service & product launches, partnerships & collaborations, and mergers & expansions to increase their presence in the global market. Koninklijke Philips (Netherlands) was one of the major players operating in the diagnostic electrocardiograph market in 2018. The com

According to the new market research report cardiac monitoring market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 The major players operating in this Cardiac Monitoring Market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), ACS Diagnostics (US), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland),

According to research report Wearable Medical Devices Market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. Wearable healthcare devices are autonomous devices that can be attached, worn, or handheld for monitoring and examining the metabolic & physiological changes that occur in the human body. These devices are also used to record data. Wearable healthcare devices monitor and diagnose many diseases such as sleep apnea, skin temperature, blood glucose level, sleep patterns, general health parameters, fitness, and wellness progress among athletes and fitness enthusiasts. These devices are also used in various therapeutic applications such as pain management, rehabilitative services, and respiratory care. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 The prominent players operating in this market include Medtronic plc (Ireland), OMRON Corporation (Japan), Ko

According to the new market research report Stable Isotope Labeled Compounds Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Cambridge Isotope Laboratories (CIL) (US), Merck KGaA (Germany), and URENCO (UK) are the key players operating in the stable isotope labeled compounds market. Other prominent players in the market include IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nip

According to the new market research report Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period. The dental equipment market is estimated to witness significant growth during the forecast period due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism. An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 The prominent players in the dental equipment industry are DENTSPLY Sirona (US), Planmeca Group (Finland), Envista Holdings (US), Align Technology (US), A-dec Inc. (US), J. MORITA CORP. (Japan), GC Corporation (Japan), Midmark Corporation (US), Straumann Holdings AG (Switzerland), 3M Company (US), BIOLASE, Inc. (US), 3Shape A/S

According to the new market research report dPCR and qPCR market is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0% between 2020 and 2025. Factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The global dPCR and qPCR market is highly competitive, with many large, medium-sized, and small market players. As of the financial year ended in March 2019, the global dPCR and qPCR market was dominated by Thermo Fisher Scientific (US), Bio-Rad Lab

According to research report the In Vitro Diagnostics Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Key players are focusing on increasing their presence in this growing market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions. Due to the intense competition in this market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Bio-Rad Laboratories Inc. (US) was the leading player in the IVD quality control market and accounted for the largest share in 2018. The company is a leading provider of clinical diagnostic systems, analytical devices, and instruments. The company has a robust portfolio of quality control products, data managemen

According to the new market research report Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Based on technology, the market is segmented into ELISA, rapid tests, western blotting, radioimmunoassays, ELISPOT and other technologies. ELISA accounted for the largest share of the market in 2020. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the stringent regulatory scenario and technical hurdles of the immunoassay products may restrict market growth to a certain extent. The immunoassay market is segmented based on product, technology, specimen, application

According to the new market research report “ Dental Equipments Market by Product (Dental Imaging Equipment (Panoramic, Sensor, Camera), Lasers, Diode Lasers, Dental Chairs, CAD/CAM, Handpieces, Dental Units, Casting Machines) & End User ( Laboratories, Hospitals, Clinics) - Global Forecast to 2026”, published by MarketsandMarkets™, the Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period. Browse in-depth TOC on “Dental Equipment Market” 314 – Tables 49 – Figures 285 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 Due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism. An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities. However, the high cost of dental imaging sy

According to the new market research report " Wearable Healthcare Devices Market by Type (Diagnostic (ECG, Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin)), Application (Fitness, RPM), Product (Smartwatch, Patch), Grade (Consumer, Clinical), Channel (Pharmacy, Online) - Global Forecast to 2025", published by MarketsandMarkets™, the global Wearable Healthcare Devices Market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 This market is largely driven by the increasing awareness of fitness and healthy lifestyles, development of technologically advanced products, growing geriatric population and subsequent increase in the incidence of chronic diseases, cost-containment in healthcare delivery, robust penetration of 3G and 4G networks for uninterrupted healthcare services, increasing penetration of smar

According to the new market research report dPCR and qPCR market is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0% between 2020 and 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 Factors such as the rising incidence of target infectious diseases and genetic disorders; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; technological advancements in PCR technologies and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use. Clinical application segment accounted for the largest share of qPCR market Based on application, the market is categorized into clinical applications (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics and Other Cli

According to the new market research report " In Vitro Diagnostics Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Molecular Diagnostics), Manufacturer (Third-party, OEM), End Users (Hospitals, Lab) - Global Forecast to 2026", published by MarketsandMarkets™, the global IVD Quality Control Market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. Browse in-depth TOC on "In Vitro Diagnostics Quality Control Market" 252 – Tables 59 – Figures 342 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 The IVD testing plays a significant role in clinical decision-making. Over the years, IVD quality control products and procedures have become mandatory in accredited clinical or medical laboratories. The applications of IVD quality control products have also widened over the years, wi

According to the new market research report Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The surging incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions are the major factors driving the growth of the market. In 2020, reagents & kits accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on the product, the immunoassay market is segmented into reagents & kits and analyzers. In 2020, the reagents & kits segment accounted the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to their repetitive purchase and massive consumption for

According to a new market research report " Preclinical Imaging Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast 2021" published by MarketsandMarkets, The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. Browse 83 market data Tables and 39 Figures spread through 161 Pages and in-depth TOC on "Preclinical Imaging (In-VIVO) Market" Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW) for the forecast period of 2016 to 2021. The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. On the bas

According to the new market research report " eHealth Market by Solutions (EMR, PACS & VNA, RIS, LIS, CVIS, Telehealth, eRx, HIE, Patient Portal, Medical Apps), Services (Remote Patient Monitoring, Diagnostic Services) End User - Global Forecast to 2025", published by MarketsandMarkets™, the eHealth Solutions Market is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period. Browse in-depth TOC on "eHealth Market" 181 – Tables 38 – Figures 270 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 Factors such as the increased adoption eHealth solutions, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the market. By-eHealth solutions, the EMR/EHR is expected to dominate the eHealth market in 2020 Based on eHealth solutions, the eHealth solutions market has been segmented into EHR

According to the new market research report “ Disposable Medical Device Sensors Market by Product (Biosensor, Image sensor, Accelerometer), Type (Strip Sensors, Invasive Sensors, Wearable Sensors), Application (Diagnostic Testing, Therapeutics, Patient Monitoring, Imaging) – Global Forecast to 2026”, published by MarketsandMarkets™, the Disposable Medical Device Sensors Market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period. Browse in-depth TOC on “Disposable Medical Device Sensors Market” 163 – Tables 34 – Figures 206 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1259 The Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for home-based medical care devices, significant technological advancements in the last few years, and government support f

According to the new market research report " Single-use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to 2026", published by MarketsandMarkets™, the global Single-Use Bioreactors Market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Browse in-depth TOC on "Single-use Bioreactors Market" 235 – Tables 32 – Figures 207 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750 Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&